Efficacy of combination theray of insulin and vildagliptin in Japanese patients with type 2 diabets

Efficacy of combination theray of insulin and vildagliptin in Japanese patients with type 2 diabets - insulin and vildagliptin

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011369

Enrollment

Registered

2013-08-05

Start date

2013-08-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetic patients

Interventions

vildagliptin 50~100mg/day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: type 2 diabetic patients under insulin therapy whose HbA1c is higher than 6.9%, fasting blood glucose is higher than 129mg/dl or post-prandial glucose is higher than 179mg/dl.

Exclusion criteria

Exclusion criteria: 1. type 1 diabetes or patients with an episode of ketosis 2. anti-GAD anibody(+) or serum CPR is lower than range 3. severe renal failure 4. other uncomfortable state

Design outcomes

Primary

Measure	Time frame
HbA1c, blood glucose, glucagon, c-peptide	—

Countries

Japan

Contacts

Public ContactTakashi Nomiyama

Fukuoka university, school of medicine Department of endocrinology ana diabetes mellitus

tnomiyama@fukuoka-u.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026